Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Poland Healthcare Report.

Healing Across Borders: Raíces Ancestrales Brings Cultural Resilience to Ukraine
Raíces joined a humanitarian delegation to Poland & Ukraine, sharing ancestral healing methods that unite trauma recovery, culture & family resilience. KYIV, KYIV OBLAST, UKRAINE, October 14, 2025 /EINPresswire.com/ -- During a recent...

Greenwich LifeSciences Announces Addition of Austria to Flamingo-01 Clinical Trial
STAFFORD, Texas, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an...

PharmaCielo Completes La Margarita Land Sale, Repays Banco Agrario Loan, Strengthens Balance Sheet, Completes Audit
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES/ All amounts expressed in Canadian dollars unless otherwise noted TORONTO and RIONEGRO, Colombia, Oct. 06, 2025 (GLOBE NEWSWIRE) -- PharmaCielo Ltd....

MAPS and HoloMind Institute Host International MDMA-Assisted Therapy Training in Poland
Training marks Poland's first International Psychedelic Therapy Training Program, expanding MAPS' global education initiative Program demonstrates MAPS' commitment to expanding global access to psychedelic healing through international...

FDA Clears Celon Pharma’s Schizophrenia Drug for Phase 3 Trial
FDA clears path for Phase 3 testing following positive Type B meeting Regulatory alignment confirms preclinical data sufficient for pivotal initiation Phase 3 to include two 28-day trials and a 12-month safety extension CPL’36 demonstrated strong...

Samantha Cushing and Luis Fernando Guadamuz Bring Raíces Ancestrales Healing Practices to Ukrainian Families in Poland
WARSAW, MASOVIAN VOIVODESHIP, POLAND, October 3, 2025 /EINPresswire.com/ -- As part of an international delegation meeting with humanitarian organizations in Warsaw, Samantha Cushing and Luis Fernando Guadamuz introduced their practice, Raíces...

Poland Implements Stricter Regulations for Ukrainian Refugees
(MENAFN) Poland’s President, Karol Nawrocki, has enacted a new law that imposes stricter requirements on Ukrainian refugees seeking access to public benefits. Although the legislation permits Ukrainians to remain in Poland until at least March...

STX Next Launches ChatGPT App Development Services as $40B Market Opens to Developers
Poznań, Wielkopolskie , Oct. 14, 2025 (GLOBE NEWSWIRE) -- STX Next today launched specialized ChatGPT app development services following OpenAI's October 6th release of the Apps SDK to developers. The agency's market analysis suggests ChatGPT apps...

Greenwich LifeSciences Announces Expansion of Flamingo-01 Clinical Trial to Belgium
STAFFORD, Texas, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an...

Pharmacovigilance Outsourcing Market Size Worth USD 12.12 Billion by 2034 Driven by Rising Clinical Trials and Stringent Regulations
Ottawa, Sept. 24, 2025 (GLOBE NEWSWIRE) -- The global pharmacovigilance outsourcing market size is expected to be worth over USD 12.12 billion by 2034, increasing from USD 5.75 billion in 2025. The industry is growing at a CAGR of 8.64 % from 2025...

Greenwich LifeSciences Announces Addition of Portugal to Flamingo-01 Clinical Trial
STAFFORD, Texas, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating GLSI-100, an...

Cosmos Health CEO Issues Letter to Shareholders: Building a Global Healthcare Powerhouse with $300M Digital Financing Facility, U.S. Manufacturing Expansion, and AI Innovation
CHICAGO, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced that its Chief Executive Officer, Greg Siokas, has...

Poland’s Premier Describes Israel’s Actions in Gaza as “Unacceptable”
(MENAFN) Polish Prime Minister Donald Tusk on Monday denounced Israel’s conduct in Gaza as completely intolerable, warning that those accountable will ultimately face repercussions. “Terrible things are happening in the Gaza Strip and the people...

Poland-Belarus Border Closure Disrupts China-EU Rail Trade
(MENAFN) Poland’s abrupt closure of its border with Belarus has effectively frozen a vital €25 billion rail freight corridor between China and the European Union, media reported, triggering immediate disruptions across time-sensitive supply...


Infermedica Achieves MDR Class IIb Certification for Its AI-Powered Medical Guidance Platform
Infermedica earns EU MDR Class IIb certification, validating its AI platform’s safety, clinical rigor, and regulatory compliance. WROCLAW, POLAND, September 24, 2025 /EINPresswire.com/ -- Infermedica, a leading provider of AI-powered digital...

Infermedica Achieves MDR Class IIb Certification for its AI-Powered Medical Guidance Platform
Infermedica earns EU MDR Class IIb certification, validating its AI platform’s safety, clinical rigor, and regulatory compliance. WROCLAW, POLAND, September 24, 2025 /EINPresswire.com/ -- Infermedica, a leading provider of AI-powered digital...

Er-Kim Enters Commercialization Agreement with Sentynl Therapeutics for Nulibry® (fosdenopterin) and Zokinvy® (lonafarnib), Targeting Ultra-Rare Diseases
ATHENS, Greece and SOLANA BEACH, Calif., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Er-Kim, an international pharmaceutical company specializing in the commercialization of novel therapies in EMEA region, today announced that it has signed an agreement...

Infermedica Achieves MDR Class IIb Certification for its AI-Powered Medical Guidance Platform
Infermedica earns EU MDR Class IIb certification, validating its AI platform’s safety, clinical rigor, and regulatory compliance. WROCLAW, POLAND, September 22, 2025 /EINPresswire.com/ -- Infermedica, a leading provider of AI-powered digital...

Infermedica Achieves MDR Class IIb Certification for its AI-Powered Medical Guidance Platform
Infermedica earns EU MDR Class IIb certification, validating its AI platform’s safety, clinical rigor, and regulatory compliance. WROCLAW, POLAND, September 22, 2025 /EINPresswire.com/ -- Infermedica, a leading provider of AI-powered digital...